ENDRA Life Sciences (NDRA) Net Income towards Common Stockholders: 2016-2024
Historic Net Income towards Common Stockholders for ENDRA Life Sciences (NDRA) over the last 9 years, with Dec 2024 value amounting to -$11.5 million.
- ENDRA Life Sciences' Net Income towards Common Stockholders fell 37.94% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.4 million, marking a year-over-year increase of 6.34%. This contributed to the annual value of -$11.5 million for FY2024, which is 14.39% down from last year.
- ENDRA Life Sciences' Net Income towards Common Stockholders amounted to -$11.5 million in FY2024, which was down 14.39% from -$10.1 million recorded in FY2023.
- ENDRA Life Sciences' 5-year Net Income towards Common Stockholders high stood at -$10.1 million for FY2023, and its period low was -$13.2 million during FY2022.
- Over the past 3 years, ENDRA Life Sciences' median Net Income towards Common Stockholders value was -$11.5 million (recorded in 2024), while the average stood at -$11.6 million.
- Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first surged by 30.84% in 2020, then declined by 16.09% in 2022.
- Yearly analysis of 5 years shows ENDRA Life Sciences' Net Income towards Common Stockholders stood at -$12.1 million in 2020, then increased by 6.34% to -$11.4 million in 2021, then decreased by 16.09% to -$13.2 million in 2022, then rose by 23.67% to -$10.1 million in 2023, then dropped by 14.39% to -$11.5 million in 2024.